Impact of an Emergency Advanced Practice Nurse on Complications After Home Discharge of Oxygen-Dependent Patients Managed in the Emergency Department: A Quantitative and Qualitative Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

Since the COVID-19 pandemic, discharging patients home on low-flow oxygen therapy has proven to be a safe and effective alternative to hospitalization, helping to relieve overcrowded hospitals while ensuring continuity of care. At the investigating emergency department, a dedicated care pathway ("Oxy-Urg") already allows selected oxygen-dependent patients to return home with a home-care provider, regardless of the cause of their breathlessness, once their condition is stable.

This study evaluates whether managing these patients with a team combining an emergency advanced practice nurse (APN) and an emergency physician, rather than a physician alone, improves the organization of care and reduces complications after home discharge.

Adult oxygen-dependent patients eligible for the Oxy-Urg pathway are randomly assigned (1:1) to management by an APN-physician team (intervention group) or by a physician alone (control group). Both groups then receive the usual Oxy-Urg pathway (home oxygen therapy, provider tele-monitoring, community nurse and general practitioner follow-up).

The main goal is to compare the number of organizational adverse events occurring between inclusion and Day 28 between the two groups. The study also assesses clinical deterioration after discharge, the time professionals spend setting up the pathway, and, through interviews and a focus group, the experience of patients and professionals. The hypothesis is that the APN-physician team allows a more efficient organization and improves the patient experience, supporting the sustainability and wider use of this pathway.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient (>= 18 years)

Affiliated to a social health insurance scheme

Able to understand the objectives and risks of the research and to give dated, signed informed consent

Stable for more than 12 hours on oxygen therapy in the emergency department

Disqualifiers

Clinical condition requiring hospitalization (decided by the senior physician, per standard of care)

Patient's refusal to enter the pathway

Patient managed outside the emergency APN's working hours

End-of-life patient

Trial design

Design model

Parallel

Treatments tested in this trial

  • APN-physician team management of the Oxy-Urg pathway

    Other intervention

    Organizational intervention: the emergency advanced practice nurse and the emergency physician jointly manage the inclusion of the patient in the Oxy-Urg pathway and the organization of the home discharge on oxygen.

  • Usual care: physician-alone management of the Oxy-Urg pathway

    Other intervention

    Usual care

Treatment groups

170 Participants
are divided into 2 treatment groups
Group A: Advanced practice nurse-physician teamExperimental treatment 1 intervention
Group B: Emergency physician alone (usual care)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Proportion of patients with at least one organizational adverse event related to home discharge on oxygen

At least one of the following organizational adverse events: (1) total pathway inclusion time greater than 20 minutes; (2) administrative error or omission regarding prescriptions, the liaison file or handover; (3) time to home oxygen availability exceeding the protocol target; (4) initial technical difficulty of the equipment requiring corrective action by the provider; (5) non-compliance with instructions given to home caregivers, evidenced by a documented non-conformity; (6) nurse visit not compliant with the prescription, observed and recorded.

Time frame
From inclusion (Day 0) to Day 28

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: